openPR Logo
Press release

Drug Screening Market Share, Trends, Reach at a CAGR of 11.33%, Covid-19 Impact, Competitive Analysis and Future Outlook 2023-2028: Markntel Advisors

11-07-2023 12:58 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: MarkNtel Advisors LLP

Drug Screening Market Share, Trends, Reach at a CAGR of 11.33%,

Markntel Advisors' recent report projects that The Global Drug Screening Market size was valued at USD 7.5 billion in 2022 and is projected to grow at a CAGR of around 11.33% during the forecast period 2023-28. This analysis, conducted by one of the foremost market research firms, provides vital insights into the market positioning of key players, covering essential aspects such as product pricing, expenses, earnings, production, capacity utilization, supply and demand dynamics, and industry growth rates. Specialized sections within the report are dedicated to SWOT analysis for emerging ventures, assessment of investment feasibility, and evaluations of investment returns. By offering a thorough examination of market segments and sub-segments, this report is designed to furnish industry leaders with the knowledge needed to make well-informed business decisions.

Request a Free Sample: https://www.marknteladvisors.com/query/request-sample/drug-screening-market.html

Global Drug Screening Market Driver
The Surge in Drug and Alcohol Consumption - According to the World Drug Report 2021 released by the United Nations Office on Drugs and Crime (UNODC) in 2022, there has been a significant 22% rise in the number of drug users worldwide. Similarly, The UNODC's findings in 2021 revealed that approximately 200 million individuals, accounting for 4% of the global population. Moreover, the number of users witnessed an 18% increase. Additionally, around 20 million people, represent 0.4% of the global population.

According to WHO, continues to be the most prevalent illicit substance in the African Region, with West and Central Africa experiencing the highest rates of use and witnessing an alarming increase. Reported prevalence in this region ranges from 5.2% to 13.5%. As drug consumption continues to escalate among the population, the demand for drug screening services is projected to soar, subsequently fostering substantial market growth during the study period.

Read Full Report: https://www.marknteladvisors.com/research-library/drug-screening-market.html

Identifying Notable Investment Opportunities in the Drug Screening Market
Making wise investment choices is essential for individuals seeking to enhance their gains within the Drug Screening Market. Our analysis aims to identify dependable investment hubs, considering factors like projected demand, expected profits, profit margins, and market stability. By assessing these elements, clients can channel their investments into pivotal hubs that offer the most encouraging prospects. This strategic approach enables clients to optimize their investment portfolio and attain sustained growth in the Drug Screening Market. The Drug Screening Market examination is divided into multiple branches and further sub-divisions for a thorough analysis, ultimately designed to furnish stakeholders with invaluable insights. The market is categorized as follows:

By Product & Service
• Drug Screening Product
• Analytical Instruments
• Rapid Testing Devices
• Oral Fluid Testing Devices
• Consumables

By Sample Type
• Urine Samples
• Breath Samples
• Oral Fluid Samples
• Hair Samples
• Others

By End Users
• Drug Testing Laboratories
• Workplaces
• Criminal Justice & Law Enforcement Agencies
• Hospitals
• Drug Treatment Centers
• Individual Users
• Pain Management Centers
• Schools & Colleges

By Region
• North America
• South America
• Europe
• Asia-Pacific
• The Middle East and Africa

"In case you missed it, we are currently revising our reports. Click on the "request sample report" button to get the most latest research data with forecast for years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn't take long for the team to deliver the most recent version of the report."

Click Here to Customize the Report: https://www.marknteladvisors.com/query/request-customization/drug-screening-market.html

Assessing Potential Business Collaborators in the Drug Screening Market
The noteworthy entities featured in the Drug Screening Market research report include Labcorp, Quest Diagnostics, Abbott Laboratories, Orasure Technologies, Alfa Scientific Designs, ThermoFisher Scientific, Dragewerk, Lifeloc Technologies, MPD Inc., Omega Laboratories, Premier Biotech, Psychmedics, Siemens Healthineers, Shimadzu Corporation, Hoffmann-La Roche Ltd., Others. Collaboration and partnerships play a significant role in the success of enterprises operating in the Drug Screening Market. Our services aid clients in the efficient identification and assessment of potential business collaborators. Through our research and observations, we offer valuable insights into the credibility, dependability, and competencies of prospective partners. This equips clients to make informed decisions regarding partnerships, ensuring alignment with organizations that share their vision and can contribute positively to their business goals within the Drug Screening Market.

Related Report:

https://www.marknteladvisors.com/research-library/cell-gene-therapy-drug-delivery-devices-market.html

https://www.marknteladvisors.com/research-library/global-autoimmune-disorder-drug-delivery-devices-market.html

This all-encompassing report on the Drug Screening Market Analysis seeks to answer the following key questions:
• What is the estimated value of the Drug Screening Market, specifically for the year 2028?
• What prevailing trends are discernible in the Drug Screening Market, and are there indicators of potential growth or decline in market demand in the years ahead?
• How are the projections for the Drug Screening Market derived, considering factors such as production, capacity, production value, anticipated costs, profits, market share, supply, consumption, import, and export dynamics?
• What is the expected demand for various product categories and their potential applications across industries within the market?

Nick
Call us: +1 628 895 8081, +91 120 4278433
Email: sales@marknteladvisors.com
Corporate Office: Office No.106, H-160, Sector 63, Noida, Uttar Pradesh - 201301, India

MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Screening Market Share, Trends, Reach at a CAGR of 11.33%, Covid-19 Impact, Competitive Analysis and Future Outlook 2023-2028: Markntel Advisors here

News-ID: 3279061 • Views:

More Releases from MarkNtel Advisors LLP

Global Managed SIEM Services Market Reach USD 7.12 Billion in 2023, and Growing at a CAGR of 17.4% Till 2030 | IBM, SAP, and Oracle
Global Managed SIEM Services Market Reach USD 7.12 Billion in 2023, and Growing …
Latest Market Study report by MarkNtel Advisors: Leading market research company, Title "Global Managed SIEM Services Market- By Application (Log Management & Reporting, Threat Intelligence, Security Analytics), Others, By Type (Fully Managed, Co-managed, By Deployment mode (On-premises, Cloud)" and other forecast 2024-30". This detailed report provides a thorough look at the industry, covering key aspects like the Managed SIEM Services Market Size, its growth in share, development, and the top companies
GCC Digital Advertising Market Poised for a 9.42% CAGR | Market Segment By Trading Platform, Advertising Media and Forecast 2030
GCC Digital Advertising Market Poised for a 9.42% CAGR | Market Segment By Tradi …
Latest Market Study report by MarkNtel Advisors: Leading market research company, Title "GCC Digital Advertising Market- By Trading Platform (Real-Time Bidding (RTB), Private Marketplace Guaranteed, Automated Guaranteed, Unreserved Fixed-rate), By Advertising Media (Digital Display, Mobile Display)" and other forecast 2024-30". This detailed report provides a thorough look at the industry, covering key aspects like the GCC Digital Advertising Market Size, its growth in share, development, and the top companies involved. It
Stable Growth Predicted for Autonomous Car Software Market with a 27.01% CAGR by 2030 | AiMotive, Baidu Inc., and BlackBerry Ltd
Stable Growth Predicted for Autonomous Car Software Market with a 27.01% CAGR by …
Latest Market Study report by MarkNtel Advisors: Leading market research company, Title "Global Autonomous Car Software Market- By Autonomy Level (Level 1, Level 2, Level 3, Level 4, Level 5), By Software Type (Perception & Planning Software, Operating System, Middleware Software, Chauffeur Software, Interior Sensing Software, Supervision/Monitoring Software)" and other forecast 2024-30". This detailed report provides a thorough look at the industry, covering key aspects like the Autonomous Car Software Market
Asia-Pacific Human Insulin Market to Grow at a CAGR of 8.12% Until 2030 | Becton, Dickinson and Company (BD), and Biocon Limited
Asia-Pacific Human Insulin Market to Grow at a CAGR of 8.12% Until 2030 | Becton …
Latest Market Study report by MarkNtel Advisors: Leading market research company, Title "Asia-Pacific Human Insulin Market- By Type (Human Insulin Biologics, Intermediate Acting, Short Acting, Premixed), Insulin Analogue & Biosimilar, [Long Acting, Rapid Acting, Premixed]), By Application, (Diabetes Type 1, Diabetes Type 2)," and other forecast 2024-30". This detailed report provides a thorough look at the industry, covering key aspects like the Asia-Pacific Human Insulin Market Size, its growth in

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug